Transfusion and the human immunodeficiency virus
1993; Wiley; Volume: 33; Issue: 2 Linguagem: Inglês
10.1046/j.1537-2995.1993.33293158038.x
ISSN1537-2995
Autores Tópico(s)Hepatitis B Virus Studies
ResumoTransfusionVolume 33, Issue 2 p. 101-102 Free Access Transfusion and the human immunodeficiency virus Henry H. Balfour Jr. MD, Henry H. Balfour Jr. MD Department of Laboratory Medicine and Pathology and Department of Pediatrics University of Minnesota Hospital and Clinics Box 437 UMHC 15–144 Phillips-Wangensteen Building Harvard Street at East River Road Minneapolis, MN 55455-0392Search for more papers by this author Henry H. Balfour Jr. MD, Henry H. Balfour Jr. MD Department of Laboratory Medicine and Pathology and Department of Pediatrics University of Minnesota Hospital and Clinics Box 437 UMHC 15–144 Phillips-Wangensteen Building Harvard Street at East River Road Minneapolis, MN 55455-0392Search for more papers by this author First published: February 1993 https://doi.org/10.1046/j.1537-2995.1993.33293158038.xCitations: 6AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. References 1 Vamvakas E., Kaplan HS. Early transfusion and length of survival in acquired immune deficiency syndrome: experience with a population receiving medical care at a public hospital. Transfusion 1993; 33: 111– 8. 2 Scadden DT, Zeira M., Woon A., et al. Human immunodeficiency virus infection of human bone marrow stromal fïbroblasts. Blood 1990; 76: 317– 22. 3 Busch MP, Lee TH, Heitman J. Allogeneic leukocytes but not therapeutic blood elements induce reactivation and dissemination of latent human immunodeficiency virus type 1 infection: implications for transfusion support of infected patients. Blood 1992; 80: 2128– 35. 4 Klein HG. Wolf in wolf's clothing: is it time to raise the bounty on the passenger leukocyte? (editorial). Blood 1992; 80: 1865– 8. 5 Blumberg N., Heal JM. Transfusion and recipient immune function. Arch Pathol Lab Med 1989; 113: 246– 53. 6 Fischl M., Galpin JE, Levine JD, et al. Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med 1990; 322: 1488– 93. 7 Balfour HH Jr, Abels R. Recombinant human erythropoietin (r-HuEPO) treatment IND (T-IND) for anemia in persons with AIDS not receiving zidovudine (AZT). Presented at the Eighth International Conference on AIDS, Amsterdam, The Netherlands, July 1924, 1992. Citing Literature Volume33, Issue2February 1993Pages 101-102 ReferencesRelatedInformation
Referência(s)